홈 > 시장보고서 > 의료기기 > 바이오장비

시장보고서

상품코드

1671162

세계의 스캐폴드 기술 시장 규모, 점유율, 동향, 업계 분석 : 종류별, 질환 종류별, 용도별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Scaffold Technology Market Size, Share, Trends, Industry Analysis Report: By Type, Disease Type, Application, End Users, and Region - Market Forecast, 2025-2034

발행일: 2025년 02월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 2034년까지 전 세계 스캐폴드 기술 시장 규모는 80억 4,672만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

스캐폴드 기술은 조직 재생 및 장기 성장을 지원하기 위해 3D 스캐폴드를 사용하는 바이오테크놀러지 프로세스입니다. 스캐폴드는 세포가 조직을 형성할 수 있는 화학적, 기계적 환경을 제공하는 섬유질의 침투성 생체 재료입니다. 스캐폴드는 일반적으로 세포의 접착을 지원하고, 조직의 모양과 크기를 규정하며, 제어 신호를 공급하고, 원래의 조직을 모방하기 위해 사용됩니다.

생체재료와 나노기술의 혁신은 조직 복구 및 재생에 있어 스캐폴드의 효능을 향상시키고 있으며, 이는 스캐폴드 기술 시장의 성장을 촉진하고 있습니다. 조직공학을 발전시키기 위한 정부 및 민간단체의 자금 지원과 투자 증가가 시장 개척을 뒷받침하고 있습니다.

개별 환자의 해부학적 구조에 따라 맞춤형 스캐폴드를 개발하기 위한 3D 프린팅의 채택이 증가함에 따라 향후 몇 년 동안 스캐폴드 기술 시장의 성장을 지원할 것으로 예상되며, 2D 및 3D 세포배양 기술의 발전은 예측 기간 동안 시장 진입자에게 유리한 기회를 창출할 것으로 예상됩니다. 시장 진입자들에게 유리한 기회를 창출할 것으로 예상됩니다.

스캐폴드 기술 시장 : 분석 개요

유형별로는 하이드로겔 분야가 2024년 43.18%의 매출 점유율로 세계 스캐폴드 기술 시장을 주도했습니다. 이는 하이드로겔의 미세 가공 절차의 기술 발전으로 인해 조직 공학 응용 분야에서 하이드로겔의 사용이 증가했기 때문입니다.

질병 유형별로는 신경 분야가 2025년부터 2034년까지 가장 높은 CAGR 15.91%를 기록할 것으로 예측됩니다. 이는 새로운 스캐폴드 개발을 위한 연구개발의 증가와 신경 재생 장애 치료에 있어 재생의학 및 줄기세포 치료의 채택 증가에 기인합니다.

북미는 2024년 43.41%의 매출 점유율로 스캐폴드 기술 시장을 장악했으며, 이는 스캐폴드 기술에 대한 연구 및 자금 지원 증가, 줄기세포 연구 및 재생의료의 최근 발전, 이 지역의 주요 기업의 존재 등에 기인한 것으로 분석됩니다.

아시아태평양의 스캐폴드 기술 시장은 예측 기간 동안 13.9%의 가장 높은 CAGR을 기록할 것으로 예상되며, 이는 줄기세포 연구에 대한 정부의 관심이 높아졌기 때문입니다.

Merck KGaA, Thermo Fisher Scientific, Inc., Pelobiotech, Corning Incorporated, Avacta Life Sciences Limited, Vericel Corporation, Becton, Dickinson and Company, 3D Biotek LLC, Xanofi, Molecular Matrix Inc., REPROCELL Inc., Matricel GmbH, Akron Biotech, Nanofiber Solutions, 4titude, 3D BioMatrix, NuVasive, Inc., Allergan, Medtronic은 이 시장의 주요 기업 중 일부입니다.

시장 현황
스캐폴드 기술 시장 역학
- 성장 촉진요인과 기회
  - 바이오소재와 나노기술의 진보
  - 재생의료에 대한 투자 증가
- 성장 억제요인과 과제
  - 규제상 허들과 장기간의 승인 프로세스
PESTLE 분석
스캐폴드 기술 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 스캐폴드 기술 시장 : 종류별

주요 분석 결과
소개
하이드로겔
폴리머 스캐폴드
마이크로 패턴 표면 마이크로플레이트
나노섬유 기반 스캐폴드

제6장 세계의 스캐폴드 기술 시장 : 질환 종류별

주요 분석 결과
소개
정형외과, 근골격, 척추
암
피부와 외피
치과
심혈관 학
신경학
비뇨기과
부인과
기타

제7장 세계의 스캐폴드 기술 시장 : 용도별

주요 분석 결과
소개
줄기세포 치료, 재생의료, 조직공학
Drug Discovery
기타

제8장 세계의 스캐폴드 기술 시장 : 최종사용자별

주요 분석 결과
소개
바이오테크놀러지·제약 산업
연구실·연구기관
병원·진단 센터
기타

제9장 세계의 스캐폴드 기술 시장 : 지역별

주요 분석 결과
소개
- 스캐폴드 기술 시장 평가 : 지역별(2020-2034년)
북미
- 북미 : 종류별(2020-2034년)
- 북미 : 질환 종류별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종사용자별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 종류별(2020-2034년)
- 유럽 : 질환 종류별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 종류별(2020-2034년)
- 아시아태평양 : 질환 종류별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 종류별(2020-2034년)
- 중동 및 아프리카 : 질환 종류별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 종류별(2020-2034년)
- 라틴아메리카 : 질환 종류별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
제휴/협업/합의/공개

제11장 기업 개요

Merck KGaA
Thermo Fisher Scientific, Inc.
Pelobiotech
Corning Incorporated
Avacta Life Sciences Limited
Vericel Corporation
Becton, Dickinson and Company
3D Biotek LLC
Xanofi
Molecular Matrix Inc.
REPROCELL Inc.
Matricel GmbH
Akron Biotech
Nanofiber Solutions
4titude
3D BioMatrix
NuVasive, Inc.
Allergan
Medtronic

ksm 25.04.01

The global scaffold technology market size is expected to reach USD 8,046.72 million by 2034, according to a new study by Polaris Market Research. The report "Scaffold Technology Market Size, Share, Trends, Industry Analysis Report: By Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, and Nanofiber Based Scaffolds), Disease Type, Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Scaffold technology is a process in biotechnology that employs 3D scaffolds to support tissue regeneration and organ growth. Scaffolds are fibrous, permeable biomaterials that provide a chemical and mechanical environment for cells to form tissues. Scaffolds are typically used to support cell attachment, define tissue shape and size, provide regulatory signals, and mimic native tissues.

Innovations in biomaterials and nanotechnology, which are improving the efficacy of scaffolds in tissue repair and regeneration, are driving the scaffold technology market growth. Increased funding and investments from government and private entities to advance tissue engineering support the market development.

The rising adoption of 3D printing to develop customized scaffolds based on the anatomy of an individual patient is projected to support scaffold technology market expansion in the coming years. Advancements in 2D and 3D cell culture techniques are anticipated to create lucrative opportunities for market participants during the forecast period.

Key Highlights of Scaffold Technology Market Report

Based on type, the hydrogels segment led the global scaffold technology market with a revenue share of 43.18% in 2024, as technological advancements in microfabrication procedures for hydrogels have resulted in their increased utilization in tissue engineering applications.

Based on disease type, the neurology segment is anticipated to register the highest CAGR of 15.91% from 2025 to 2034, owing to rising research efforts for the development of new scaffolds and the increasing adoption of regenerative medicine and stem cell therapy in the treatment of neurogenerative disorders.

North America dominated the scaffold technology market with a revenue share of 43.41% in 2024, driven by an increase in research and funding toward scaffolding technology, recent advancements in stem cell research and regenerative medicine, and the presence of prominent players in the region.

The Asia Pacific scaffold technology market is anticipated to register the highest CAGR of 13.9% during the forecast period, owing to the rising government focus on stem cell research.

Merck KGaA; Thermo Fisher Scientific, Inc.; Pelobiotech; Corning Incorporated; Avacta Life Sciences Limited; Vericel Corporation; Becton, Dickinson and Company; 3D Biotek LLC; Xanofi; Molecular Matrix Inc.; REPROCELL Inc.; Matricel GmbH; Akron Biotech; Nanofiber Solutions; 4titude; 3D BioMatrix; NuVasive, Inc.; Allergan; and Medtronic are a few of the key players in the market.

Polaris Market Research has segmented the scaffold technology market research report on the basis of type, disease type, application, end users, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Hydrogels
Polymeric Scaffolds
Micropatterned Surface Microplates
Nanofiber Based Scaffolds

By Disease Type Outlook (Revenue - USD Million, 2020-2034)

Orthopedics, Musculoskeletal, and Spine
Cancer
Skin & Integumentary
Dental
Cardiology & Vascular
Neurology
Urology
Gynecology
Others

By Application Outlook (Revenue - USD Million, 2020-2034)

Stem Cell Therapy, Regenerative Medicine, and Tissue Engineering
Drug Discovery
Others

By End Users Outlook (Revenue - USD Million, 2020-2034)

Biotechnology and Pharmaceutical Industries
Research Laboratories and Institutes
Hospitals and Diagnostic Centers
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Scaffold Technology Market Insights

4.1. Scaffold Technology Market - Market Snapshot
4.2. Scaffold Technology Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Biomaterials and Nanotechnology
  - 4.2.1.2. Increased Investments in Regenerative Medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory Hurdles and Lengthy Approval Processes
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry Among Existing Firms (High)
4.4. PESTEL Analysis
4.5. Scaffold Technology Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Scaffold Technology Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Scaffold Technology Market, by Type, 2020-2034 (USD Million)
5.3. Hydrogels
- 5.3.1. Global Scaffold Technology Market, by Hydrogels, by Region, 2020-2034 (USD Million)
5.4. Polymeric Scaffolds
- 5.4.1. Global Scaffold Technology Market, by Polymeric Scaffolds, by Region, 2020-2034 (USD Million)
5.5. Micropatterned Surface Microplates
- 5.5.1. Global Scaffold Technology Market, by Micropatterned Surface Microplates, by Region, 2020-2034 (USD Million)
5.6. Nanofiber Based Scaffolds
- 5.6.1. Global Scaffold Technology Market, by Nanofiber Based Scaffolds, by Region, 2020-2034 (USD Million)

6. Global Scaffold Technology Market, by Disease Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
6.3. Orthopedics, Musculoskeletal, and Spine
- 6.3.1. Global Scaffold Technology Market, by Orthopedics, Musculoskeletal, and Spine, by Region, 2020-2034 (USD Million)
6.4. Cancer
- 6.4.1. Global Scaffold Technology Market, by Cancer, by Region, 2020-2034 (USD Million)
6.5. Skin & Integumentary
- 6.5.1. Global Scaffold Technology Market, by Skin & Integumentary, by Region, 2020-2034 (USD Million)
6.6. Dental
- 6.6.1. Global Scaffold Technology Market, by Dental, by Region, 2020-2034 (USD Million)
6.7. Cardiology & Vascular
- 6.7.1. Global Scaffold Technology Market, by Cardiology & Vascular, by Region, 2020-2034 (USD Million)
6.8. Neurology
- 6.8.1. Global Scaffold Technology Market, by Neurology, by Region, 2020-2034 (USD Million)
6.9. Urology
- 6.9.1. Global Scaffold Technology Market, by Urology, by Region, 2020-2034 (USD Million)
6.10. Gynecology
- 6.10.1. Global Scaffold Technology Market, by Gynecology, by Region, 2020-2034 (USD Million)
6.11. Others
- 6.11.1. Global Scaffold Technology Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Scaffold Technology Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Scaffold Technology Market, by Application, 2020-2034 (USD Million)
7.3. Stem Cell Therapy, Regenerative Medicine, and Tissue Engineering
- 7.3.1. Global Scaffold Technology Market, by Stem Cell Therapy, Regenerative Medicine, and Tissue Engineering, by Region, 2020-2034 (USD Million)
7.4. Drug Discovery
- 7.4.1. Global Scaffold Technology Market, by Drug Discovery, by Region, 2020-2034 (USD Million)
7.5. Others
- 7.5.1. Global Scaffold Technology Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Scaffold Technology Market, by End Users

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
8.3. Biotechnology and Pharmaceutical Industries
- 8.3.1. Global Scaffold Technology Market, by Biotechnology and Pharmaceutical Industries, by Region, 2020-2034 (USD Million)
8.4. Research Laboratories and Institutes
- 8.4.1. Global Scaffold Technology Market, by Research Laboratories and Institutes, by Region, 2020-2034 (USD Million)
8.5. Hospitals and Diagnostic Centers
- 8.5.1. Global Scaffold Technology Market, by Hospitals and Diagnostic Centers, by Region, 2020-2034 (USD Million)
8.6. Others
- 8.6.1. Global Scaffold Technology Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Scaffold Technology Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Scaffold Technology Market Assessment, by Geography, 2020-2034 (USD Million)
9.3. Scaffold Technology Market - North America
- 9.3.1. North America: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
- 9.3.2. North America: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
- 9.3.3. North America: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
- 9.3.4. North America: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.3.5. Scaffold Technology Market - US
  - 9.3.5.1. US: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.3.5.2. US: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.3.5.3. US: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.3.5.4. US: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.3.6. Scaffold Technology Market - Canada
  - 9.3.6.1. Canada: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
9.4. Scaffold Technology Market - Europe
- 9.4.1. Europe: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
- 9.4.2. Europe: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.3. Europe: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
- 9.4.4. Europe: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.5. Scaffold Technology Market - UK
  - 9.4.5.1. UK: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.6. Scaffold Technology Market - France
  - 9.4.6.1. France: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.6.2. France: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.6.3. France: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.6.4. France: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.7. Scaffold Technology Market - Germany
  - 9.4.7.1. Germany: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.8. Scaffold Technology Market - Italy
  - 9.4.8.1. Italy: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.9. Scaffold Technology Market - Spain
  - 9.4.9.1. Spain: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.10. Scaffold Technology Market - Netherlands
  - 9.4.10.1. Netherlands: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.11. Scaffold Technology Market - Russia
  - 9.4.11.1. Russia: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.4.12. Scaffold Technology Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
9.5. Scaffold Technology Market - Asia Pacific
- 9.5.1. Asia Pacific: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.5. Scaffold Technology Market - China
  - 9.5.5.1. China: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.5.2. China: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.5.3. China: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.5.4. China: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.6. Scaffold Technology Market - India
  - 9.5.6.1. India: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.6.2. India: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.6.3. India: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.6.4. India: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.7. Scaffold Technology Market - Malaysia
  - 9.5.7.1. Malaysia: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.8. Scaffold Technology Market - Japan
  - 9.5.8.1. Japan: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.9. Scaffold Technology Market - Indonesia
  - 9.5.9.1. Indonesia: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.10. Scaffold Technology Market - South Korea
  - 9.5.10.1. South Korea: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.11. Scaffold Technology Market - Australia
  - 9.5.11.1. Australia: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.5.12. Scaffold Technology Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
9.6. Scaffold Technology Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.6.5. Scaffold Technology Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.6.6. Scaffold Technology Market - UAE
  - 9.6.6.1. UAE: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.6.7. Scaffold Technology Market - Israel
  - 9.6.7.1. Israel: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.6.8. Scaffold Technology Market - South Africa
  - 9.6.8.1. South Africa: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.6.9. Scaffold Technology Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
9.7. Scaffold Technology Market - Latin America
- 9.7.1. Latin America: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
- 9.7.2. Latin America: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
- 9.7.3. Latin America: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
- 9.7.4. Latin America: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.7.5. Scaffold Technology Market - Mexico
  - 9.7.5.1. Mexico: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.7.6. Scaffold Technology Market - Brazil
  - 9.7.6.1. Brazil: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.7.7. Scaffold Technology Market - Argentina
  - 9.7.7.1. Argentina: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)
- 9.7.8. Scaffold Technology Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Scaffold Technology Market, by Type, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Scaffold Technology Market, by Disease Type, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Scaffold Technology Market, by Application, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Scaffold Technology Market, by End Users, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Merck KGaA
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Thermo Fisher Scientific, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Pelobiotech
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Corning Incorporated
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Avacta Life Sciences Limited
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Vericel Corporation
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Becton, Dickinson and Company
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. 3D Biotek LLC
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Xanofi
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Molecular Matrix Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. REPROCELL Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Matricel GmbH
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Akron Biotech
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Nanofiber Solutions
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. 4titude
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
11.16. 3D BioMatrix
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
11.17. NuVasive, Inc.
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
11.18. Allergan
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
11.19. Medtronic
- 11.19.1. Company Overview
- 11.19.2. Financial Performance
- 11.19.3. Product Benchmarking
- 11.19.4. Recent Development

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,250

￦ 6,149,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250

￦ 7,596,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 9,043,000

※ 부가세 별도